Pilocytic Astrocytoma
Authors:
- 25 February 2013
- journal article
- review article
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 28 (5) , 625-632
Abstract
Pilocytic astrocytoma, the most common pediatric brain tumor, is a clinically and molecularly heterogeneous disease that occurs most often in the cerebellum and hypothalamic and chiasmatic regions. Classically, pilocytic astrocytomas are driven by the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Recently described genetic aberrations involving this pathway are critical for tumorigenesis. Tandem duplication of 7q34 encodes BRAF and produces several KIAA1549-BRAF novel oncogenic fusions. Activating point mutations of BRAF, such as BRAFV600E, also lead to pilocytic astrocytoma. Loss of the NF1 gene allows hyperactivation of the oncogene KRAS. In this review, we discuss the current understanding of the novel molecular aberrations described in pilocytic astrocytomas and their clinical relevance for prognosis and treatment. The prognostic indications of these aberrations are discussed with regard to tumor location, tumor pathology, and patient age. A better understanding of the evolving molecular heterogeneity of pilocytic astrocytomas offers hope for developing molecularly targeted therapeutic armamentariums.Keywords
This publication has 52 references indexed in Scilit:
- Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomasNeuro-Oncology, 2012
- MAPK pathway activation in pilocytic astrocytomaCellular and Molecular Life Sciences, 2011
- RAFgene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomologyGenome Research, 2011
- PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytomaActa Neuropathologica, 2010
- Initial testing (stage 1) of AZD6244 (ARRY‐142886) by the pediatric preclinical testing programPediatric Blood & Cancer, 2010
- MEK1 mutations confer resistance to MEK and B-RAF inhibitionProceedings of the National Academy of Sciences, 2009
- Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumoursBritish Journal of Cancer, 2009
- Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytomaOncogene, 2009
- Gliomas in Neurofibromatosis Type 1: A Clinicopathologic Study of 100 PatientsJournal of Neuropathology & Experimental Neurology, 2008
- Mutations of the BRAF gene in human cancerNature, 2002